Profund Advisors
NVO icon

Profund Advisors’s Novo Nordisk NVO Stock Holding History

Profund Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$829K Buy
21,874
+2,352
+12% +$108K 0.02% 410
2026
Q2 		$936K Sell
19,522
-562
-3% -$24.1K 0.03% 365
2026
Q1 		$738K Sell
20,084
-3,126
-13% -$148K 0.03% 432
2025
Q4 		$1.18M Buy
23,210
+14,367
+162% +$735K 0.04% 313
2025
Q3 		$491K Sell
8,843
-2,169
-20% -$127K 0.02% 516
2025
Q2 		$760K Buy
11,012
+380
+4% +$25.8K 0.03% 365
2025
Q1 		$738K Buy
10,632
+3,711
+54% +$306K 0.03% 368
2024
Q4 		$595K Buy
+6,921
New +$748K 0.02% 428
2023
Q4 		– Sell
-13,427
Closed -$1.22M – 1148
2023
Q3 		$1.22M Sell
13,427
-795
-6% -$70K 0.07% 238
2023
Q2 		$1.15M Sell
14,222
-2,722
-16% -$222K 0.06% 287
2023
Q1 		$1.35M Buy
16,944
+1,294
+8% +$91.8K 0.08% 213
2022
Q4 		$1.06M Buy
15,650
+2,618
+20% +$153K 0.07% 256
2022
Q3 		$649K Sell
13,032
-1,468
-10% -$78.6K 0.05% 321
2022
Q2 		$808K Sell
14,500
-1,346
-8% -$74.7K 0.05% 304
2022
Q1 		$880K Sell
15,846
-88
-0.6% -$4.52K 0.04% 354
2021
Q4 		$892K Sell
15,934
-11,654
-42% -$631K 0.03% 367
2021
Q3 		$1.32M Buy
27,588
+1,152
+4% +$55.7K 0.04% 283
2021
Q2 		$1.11M Buy
26,436
+710
+3% +$27.5K 0.04% 326
2021
Q1 		$867K Buy
25,726
+908
+4% +$32.3K 0.03% 354
2020
Q4 		$867K Buy
24,818
+710
+3% +$24.5K 0.04% 349
2020
Q3 		$837K Sell
24,108
-4,464
-16% -$149K 0.04% 317
2020
Q2 		$935K Buy
28,572
+5,184
+22% +$165K 0.05% 282
2020
Q1 		$704K Sell
23,388
-7,168
-23% -$213K 0.05% 288
2019
Q4 		$884K Sell
30,556
-3,458
-10% -$95.8K 0.04% 387
2019
Q3 		$879K Sell
34,014
-4,546
-12% -$115K 0.04% 363
2019
Q2 		$984K Buy
38,560
+544
+1% +$13.4K 0.05% 373
2019
Q1 		$994K Buy
38,016
+6,226
+20% +$153K 0.05% 339
2018
Q4 		$732K Buy
+31,790
New +$706K 0.05% 353

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Profund Advisors's NVO Position: Q3 2026 in Review

Profund Advisors increased its Novo Nordisk (NVO) stake by 12% in Q3 2026, buying an estimated $108K and bringing the position to 21,874 shares worth $829K. The position accounts for 0.02% of the portfolio, ranked #410.

Profund Advisors first reported a position in NVO in Q4 2018 and has held it in 28 quarters since. The position peaked at $1.35M in Q1 2023. 816 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Profund Advisors held 21,874 shares of Novo Nordisk worth $829K as of Q3 2026.
  • Profund Advisors bought 2,352 Novo Nordisk shares in Q3 2026, an estimated $108K.
  • Novo Nordisk made up 0.02% of Profund Advisors's portfolio in Q3 2026, its #410 holding.
  • Profund Advisors first reported a position in Novo Nordisk in Q4 2018 and has held it in 28 quarters since.
  • Profund Advisors's Novo Nordisk position peaked at $1.35M in Q1 2023.
  • 816 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.